Delivery Order SPE2DB25D7067-SPE2DB25FSVKV
- Not listed
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Savella 50 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $1,412.55, is set to be completed by August 25, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a non-set-aside, competitively awarded procurement and serves as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, valued at $5,835.91, with an ultimate completion date of October 28, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 22, 2025, with a ceiling value of $8,031.09 and an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price contract is classified as a delivery order, indicating it falls under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Savella 50 mg tablets (60-count units) with a contract value of $26,478.90. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Savella (milnacipran) 100 mg tablets in a 60-count quantity. This is a firm fixed-price, non-set-aside contract with a ceiling value of $3,669.15 and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,309.08 firm fixed price delivery order is for the supply of Savella 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 tablets of the medication Savella 25 mg. The contract, valued at $1,149.00, has a completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVKVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Savella 50 mg tablets (60 count) under a firm fixed-price contract. The contract, valued at $15,609.03, is scheduled for completion by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside restrictions, reflecting the contractor's capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, leverages this comprehensive prime contract vehicle to supply a wide range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally. The company's federal contract portfolio demonstrates consistent performance in delivering specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains to defense health entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 7/29/25 |